Related references
Note: Only part of the references are listed.Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial
Anita H. Clayton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2023)
Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Anita H. Clayton et al.
JOURNAL OF CLINICAL PSYCHIATRY (2023)
Update on GPCR-based targets for the development of novel antidepressants
Ioannis Mantas et al.
MOLECULAR PSYCHIATRY (2022)
AMPA Receptor Function in Hypothalamic Synapses
Maria Royo et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2022)
Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala
Pantelis Antonoudiou et al.
BIOLOGICAL PSYCHIATRY (2022)
Development of neuroactive steroids for the treatment of postpartum depression
Handan Gunduz-Bruce et al.
JOURNAL OF NEUROENDOCRINOLOGY (2022)
GABA-B receptors enhance GABA-A receptor currents by modulation of membrane trafficking in dentate gyrus granule cells
Ning Li et al.
NEUROSCIENCE LETTERS (2022)
Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review
Jurriaan F. M. Strous et al.
FRONTIERS IN NEUROANATOMY (2022)
DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder
Elad Lax
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2022)
Epigenetic Mechanism of Early Life Stress-Induced Depression: Focus on the Neurotransmitter Systems
Ziqian Cheng et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection
Siqi Wang et al.
BRAIN SCIENCES (2022)
Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI)
Dan V. Iosifescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2022)
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Alize J. Ferrari et al.
LANCET PSYCHIATRY (2022)
An altered global DNA methylation status in women with depression
Edyta Reszka et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making
Margaret E. Gerbasi et al.
JOURNAL OF WOMENS HEALTH (2021)
Cortical structural differences in major depressive disorder correlate with cell type-specific transcriptional signatures
Jiao Li et al.
NATURE COMMUNICATIONS (2021)
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Zezhi Li et al.
NEUROSCIENCE BULLETIN (2021)
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium
Nooshin Javaheripour et al.
TRANSLATIONAL PSYCHIATRY (2021)
Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults A Systematic Review and Meta-analysis
Brett D. M. Jones et al.
JAMA NETWORK OPEN (2021)
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Ajay Sarawagi et al.
FRONTIERS IN PSYCHIATRY (2021)
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions
Daniel F. Levey et al.
NATURE NEUROSCIENCE (2021)
A network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults
Lu Wang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Effect of Zuranolone vs Placebo in Postpartum Depression A Randomized Clinical Trial
Kristina M. Deligiannidis et al.
JAMA PSYCHIATRY (2021)
GABAA receptors: structure, function, pharmacology, and related disorders
Amr Ghit et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2021)
SAGE-217, A Novel GABA(A) Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies
Ethan Hoffmann et al.
CLINICAL PHARMACOKINETICS (2020)
Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Bryant Lim et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2020)
Epigenetic Modifications of GABAergic Interneurons Contribute to Deficits in Adult Hippocampus Neurogenesis and Depression-Like Behavior in Prenatally Stressed Mice
Haiquan Zhong et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)
New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others
Michele Protti et al.
MEDICINAL RESEARCH REVIEWS (2020)
Brain NMDA Receptors in Schizophrenia and Depression
Albert Adell
BIOMOLECULES (2020)
The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed
Richard Balon et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2020)
Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder
Kevin M. Anderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Alison L. Althaus et al.
NEUROPHARMACOLOGY (2020)
Molecular Mechanisms of Glutamate Toxicity in Parkinson's Disease
Ji Wang et al.
FRONTIERS IN NEUROSCIENCE (2020)
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Regional GABA Concentrations Modulate Inter-network Resting-state Functional Connectivity
Xi Chen et al.
CEREBRAL CORTEX (2019)
Dissecting executive control circuits with neuron types
Tsukasa Kamigaki
NEUROSCIENCE RESEARCH (2019)
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Ariela Frieder et al.
CNS DRUGS (2019)
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaca et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression
Jamie Maguire
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Braking the Prefrontal Cortex: The Role of Glucocorticoids and Interneurons in Stress Adaptation and Pathology
Jessica M. McKlveen et al.
BIOLOGICAL PSYCHIATRY (2019)
Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
Ann M. Rasmusson et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders
Marcia H. Ratner et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors
Manasa L. Parakala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Trial of SAGE-217 in Patients with Major Depressive Disorder
Handan Gunduz-Bruce et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder
Ada M. -C. Ho et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Brain structural and functional changes in patients with major depressive disorder: a literature review
Lisong Dai et al.
PEERJ (2019)
In Search of GABAA Receptor's Neurosteroid Binding Sites
Lautaro D. Alvarez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi et al.
MOLECULAR PSYCHIATRY (2019)
Resting-state functional connectivity, cortical GABA, and neuroactive steroids in peripartum and peripartum depressed women: a functional magnetic resonance imaging and spectroscopy study
Kristina M. Deligiannidis et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
Charles F. Zorumski et al.
NEUROBIOLOGY OF STRESS (2019)
Relevance of Half-Life in Drug Design
Dennis A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive
Ada Eban-Rothschild et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?
Emmanuel Jesulola et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration
Jennifer W. Evans et al.
BIOLOGICAL PSYCHIATRY (2018)
New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
Roberto Mandrioli et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression
Bruno Romeo et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2018)
Neurosteroids: non-genomic pathways in neuroplasticity and involvement in neurological diseases
Marina Schverer et al.
PHARMACOLOGY & THERAPEUTICS (2018)
An Emerging Circuit Pharmacology of GABAA Receptors
Elif Engin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Long-Term Stress Disrupts the Structural and Functional Integrity of GABAergic Neuronal Networks in the Medial Prefrontal Cortex of Rats
Boldizsar Czeh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis
Kate E. M. Godfrey et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer-Brody et al.
LANCET (2018)
Neurosteroids in Pain Management: A New Perspective on an Old Player
Sonja L. Joksimovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Novel, Synthetic, Neuroactive Steroid Is Effective at Decreasing Depression-Like Behaviors and Improving Maternal Care in Preclinical Models of Postpartum Depression
Laverne Melon et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects
Tianze Cheng et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Neuroactive Steroids. 2.3 alpha-Hydroxy-3 beta-methyl-21-(4-cyano-1H-pyrazol-1 '-yl)-19-nor-5 beta-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (gamma-Aminobutyric Acid)(A) Receptor
Gabriel Martinez Botella et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Stephen Kanes et al.
LANCET (2017)
Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism
Amit Modgil et al.
NEUROPHARMACOLOGY (2017)
Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression
V. Gabbay et al.
TRANSLATIONAL PSYCHIATRY (2017)
Neuroactive Steroids: Receptor interactions and Responses
Kald Beshir Tuem et al.
FRONTIERS IN NEUROLOGY (2017)
Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells
Aishwarya G. Nadadhur et al.
PLOS ONE (2017)
Dysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder
Stefano Nardone et al.
CEREBRAL CORTEX (2017)
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives
Corey Fee et al.
BIOLOGICAL PSYCHIATRY (2017)
Neurosteroid biosynthesis down-regulation and changes in GABAA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment
Andrea Locci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
GABA- receptors: distinctive functions and molecular pharmacology
Moawiah M. Naffaa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener et al.
BIOLOGICAL PSYCHIATRY (2017)
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment
Zhen Ren et al.
BIOLOGICAL PSYCHIATRY (2016)
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard et al.
DRUG DISCOVERY TODAY (2016)
Brain GABA Levels Across Psychiatric Disorders: A Systematic Literature Review and Meta-Analysis of 1H-MRS Studies
Remmelt R. Schur et al.
HUMAN BRAIN MAPPING (2016)
Contrasting variability patterns in the default mode and sensorimotor networks balance in bipolar depression and mania
Matteo Martino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
Yong-Ku Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity
Jin-Chong Xu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Clinical Potential of Neurosteroids for CNS Disorders
Doodipala Samba Reddy et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Ketamine for treatment-resistant depression: recent developments and clinical applications
Jaclyn Schwartz et al.
EVIDENCE-BASED MENTAL HEALTH (2016)
Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications
Andrew W. Goddard
WORLD JOURNAL OF PSYCHIATRY (2016)
Premenstrual Dysphoric Disorder: Epidemiology and Treatment
Liisa Hantsoo et al.
CURRENT PSYCHIATRY REPORTS (2015)
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
Alan L. Pehrson et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
GABA receptors in brain development, function, and injury
Connie Wu et al.
METABOLIC BRAIN DISEASE (2015)
Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): A systematic review of randomized clinical trials
Franco De Crescenzo et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Investigation of Synapse Formation and Function in a Glutamatergic-GABAergic Two-Neuron Microcircuit
Chia-Ling Chang et al.
JOURNAL OF NEUROSCIENCE (2014)
Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings
G. Northoff et al.
MOLECULAR PSYCHIATRY (2014)
Involvement of Sigma-1 Receptors in the Antidepressant-like Effects of Dextromethorphan
Linda Nguyen et al.
PLOS ONE (2014)
Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors
Armen M. Abramian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann's area 9 (BA9) of depressed patients
Roberto Carlos Agis-Balboa et al.
PSYCHOPHARMACOLOGY (2014)
Stress-induced plasticity of GABAergic inhibition
Jamie Maguire
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
DNA Methylation/Demethylation Network Expression in Psychotic Patients with a History of Alcohol Abuse
Alessandro Guidotti et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
Glutamatergic and GABAergic TCA cycle and neurotransmitter cycling fluxes in different regions of mouse brain
Vivek Tiwari et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Postsynaptic GABAB Receptors Enhance Extrasynaptic GABAA Receptor Function in Dentate Gyrus Granule Cells
Wucheng Tao et al.
JOURNAL OF NEUROSCIENCE (2013)
GABA-Independent GABAA Receptor Openings Maintain Tonic Currents
Agnieszka I. Wlodarczyk et al.
JOURNAL OF NEUROSCIENCE (2013)
Dissecting the role of diazepam-sensitive γ-aminobutyric acid type A receptors in defensive behavioral reactivity to mild threat
Christina Koester et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Functional role of ambient GABA in refining neuronal circuits early in postnatal development
Giada Cellot et al.
FRONTIERS IN NEURAL CIRCUITS (2013)
The Clinical and Forensic Toxicology of Z-drugs
Naren Gunja
JOURNAL OF MEDICAL TOXICOLOGY (2013)
Anterior Cingulate Cortex γ-Aminobutyric Acid in Depressed Adolescents
Vilma Gabbay et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
The prevalence and natural history of urinary symptoms among recreational ketamine users
Adam R. Winstock et al.
BJU INTERNATIONAL (2012)
How theories evolved concerning the mechanism of action of barbiturates
Wolfgang Loescher et al.
EPILEPSIA (2012)
Anxiety and depression: Mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes
Kiersten S. Smith et al.
NEUROPHARMACOLOGY (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
Allopregnanolone regulates neurogenesis and depressive /anxiety-like behaviour in a social isolation rodent model of chronic stress
Jane Evans et al.
NEUROPHARMACOLOGY (2012)
Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of H-1-MRS findings
J. J. Luykx et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
α2-containing GABAA receptors: A target for the development of novel treatment strategies for CNS disorders
Elif Engin et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Benzodiazepine treatment induces subtype-specific changes in GABAA receptor trafficking and decreases synaptic inhibition
Tija C. Jacob et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cortical GABA Levels in Primary Insomnia
Peter T. Morgan et al.
SLEEP (2012)
In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice
S. A. Heldt et al.
TRANSLATIONAL PSYCHIATRY (2012)
Benzodiazepines revisited-will we ever learn?
Malcolm Lader
ADDICTION (2011)
Antidepressant-like properties of α2-containing GABAA receptors
Isabel Vollenweider et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The Noradrenergic Action in Antidepressant Treatments: Pharmacological and Clinical Aspects
Bernardo Dell'Osso et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?
G. MacQueen et al.
MOLECULAR PSYCHIATRY (2011)
The GABAergic deficit hypothesis of major depressive disorder
B. Luscher et al.
MOLECULAR PSYCHIATRY (2011)
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
NEUROSTEROID AND GABA-A RECEPTOR ALTERATIONS IN ALZHEIMER'S DISEASE, PARKINSON'S DISEASE AND MULTIPLE SCLEROSIS
S. Luchetti et al.
NEUROSCIENCE (2011)
Neuroprotective Actions of Neurosteroids
Kinga K. Borowicz et al.
Frontiers in Endocrinology (2011)
γ-Aminobutyric Acid-Type A Receptor Deficits Cause Hypothalamic-Pituitary-Adrenal Axis Hyperactivity and Antidepressant Drug Sensitivity Reminiscent of Melancholic Forms of Depression
Qiuying Shen et al.
BIOLOGICAL PSYCHIATRY (2010)
Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder
Andrea J. Levinson et al.
BIOLOGICAL PSYCHIATRY (2010)
Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results
Ursula M. H. Klumpers et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
Beata Karolewicz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation
B. S. McEwen et al.
MOLECULAR PSYCHIATRY (2010)
Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Benzodiazepine modulation of GABAA receptor opening frequency depends on activation context: A patch clamp and simulation study
Matt T. Bianchi et al.
EPILEPSY RESEARCH (2009)
The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression
Esra Kucukibrahimoglu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
Delia Belelli et al.
JOURNAL OF NEUROSCIENCE (2009)
Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis
Sarah A. Hewitt et al.
NATURE NEUROSCIENCE (2009)
GABA(A) receptors: Subtypes provide diversity of function and pharmacology
Richard W. Olsen et al.
NEUROPHARMACOLOGY (2009)
Bipolar and major depressive disorder: Neuroimaging the develop mental-degenerative divide
Jonathan Savitz et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
Adolfo Sequeira et al.
PLOS ONE (2009)
Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression
T. A. Klempan et al.
MOLECULAR PSYCHIATRY (2009)
Affective and cognitive effects of global deletion of α3-containing gamma-aminobutyric acid-A receptors
Roberto Fiorelli et al.
BEHAVIOURAL PHARMACOLOGY (2008)
GABAA receptor promoter hypermethylation in suicide brain:: Implications for the involvement of epigenetic processes
Michael O. Poulter et al.
BIOLOGICAL PSYCHIATRY (2008)
Structural mechanisms underlying benzodiazepine modulation of the GABAA receptor
Susan M. Hanson et al.
JOURNAL OF NEUROSCIENCE (2008)
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin
Kathryn G. Todd et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2008)
Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior
T. J. Sajdyk et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The hippocampus and memory: insights from spatial processing
Chris M. Bird et al.
NATURE REVIEWS NEUROSCIENCE (2008)
GABAAR plasticity during pregnancy:: Relevance to postpartum depression
Jamie Maguire et al.
NEURON (2008)
Decreased corticolimbic allopregnanolone expression during, social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder
Fabio Pibiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reduced Brain GABA in Primary Insomnia: Preliminary Data from 4T Proton Magnetic Resonance Spectroscopy (1H-MRS)
John W. Winkelman et al.
SLEEP (2008)
Suicidal Antidepressant Overdoses: A Comparative Analysis by Antidepressant Type
Nicole C. White et al.
JOURNAL OF MEDICAL TOXICOLOGY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Neuroactive steroids and human recombinant ρ1 GABAC receptors
Wenjun Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Neurosteroid binding sites on GABAA receptors
Alastair M. Hosie et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Molecular regulation of cognitive functions and developmental plasticity:: impact of GABAA receptors
Hanns Moehler
JOURNAL OF NEUROCHEMISTRY (2007)
Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection
W. B. Ruzicka et al.
MOLECULAR PSYCHIATRY (2007)
Reduction in occipital cortex γ-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects
Zubin Bhagwagar et al.
BIOLOGICAL PSYCHIATRY (2007)
Neurosteroid synthesis-mediated regulation of GABAA receptors:: Relevance to the ovarian cycle and stress
Jamie Maguire et al.
JOURNAL OF NEUROSCIENCE (2007)
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression
Grazyna Rajkowska et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Alastair M. Hosie et al.
NATURE (2006)
The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer
Lasse K. Bak et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake
Graziano Pinna et al.
PSYCHOPHARMACOLOGY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Social isolation stress-induced aggression in mice: A model to study the pharmacology of neurosteroidogenesis
K Matsumoto et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2005)
Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety
JL Maguire et al.
NATURE NEUROSCIENCE (2005)
Steroids, neuroactive steroids and neurosteroids in psychopathology
BO Dubrovsky
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Molecular structure and physiological functions of GABAB receptors
B Bettler et al.
PHYSIOLOGICAL REVIEWS (2004)
Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression
G Sanacora et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Zinc-mediated inhibition of GABAA receptors:: discrete binding sites underlie subtype specificity
AM Hosie et al.
NATURE NEUROSCIENCE (2003)
Increased cortical GABA concentrations in depressed patients receiving ECT
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine
G Pinna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Induced panic attacks shift γ-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder preliminary results
A Ströhle et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells
Z Nusser et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
β-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro
M Mori et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation
E Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mechanism of action of the hypnotic zolpidem in vivo
F Crestani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Social isolation-induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain
M Serra et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABAA receptor α1 subtype
RM McKernan et al.
NATURE NEUROSCIENCE (2000)
Novel brain function: biosynthesis and actions of neurosteroids in neurons
K Tsutsui et al.
NEUROSCIENCE RESEARCH (2000)
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
IM Anderson
JOURNAL OF AFFECTIVE DISORDERS (2000)
Share Paper
